
Rivercell raises $25M to build an AI model of how cells respond to drugs
THE SO WHAT
$25M at seed for an AI “virtual cell” is a bet that in silico biology will move from screening aid to core decision engine in drug design. Pharma and biotech operators should start mapping where such models could collapse wet-lab cycles — and what data access or validation partnerships they’d need to plug into this stack.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechChatGPT, Gemini, and Claude imitated in fake ads that steal credentials and MFA codes
Attackers impersonating ChatGPT, Gemini, and Claude in ad networks to drain advertiser accounts is a reminder that AI brands are now prime phishing payloads. If you run paid media or manage high-limit ad accounts, treat any “AI assistant” browser install as hostile by default and tighten MFA, device policies, and spend alerts this week.
Deep & Emerging TechApollo's Cortese Says Liquidity Is a Virtue, Not a Vice
Apollo projecting $100T in debt financing over the next decade — with 20% pointed at AI digital infrastructure per Bloomberg — means credit markets, not just equity, will underwrite the AI buildout. If you’re planning large-scale infra, expect more structured debt options and start building relationships with private credit desks, not just VCs and banks.
Deep & Emerging TechApollo’s Push for Private Credit Transparency
Apollo putting daily marks on an $850B private credit book and trading $35B of it is about turning illiquid loans into something closer to a tradeable asset class. For operators, more transparent, liquid private credit could widen your financing options for capex-heavy projects — but also expose you to faster repricing if performance slips.
Deep & Emerging TechAmazon’s About You page goes viral for what it guesses about shoppers
Amazon’s “About You” page going viral for calling out traits like “flat buttocks” is a live case study in how opaque inference systems collide with user perception. If you’re inferring sensitive attributes, assume screenshots will hit social — build explicit controls for what’s surfaced to users versus kept strictly for internal targeting.